Zoetis (NYSE:ZTS – Get Free Report) and Vifor Pharma (OTCMKTS:GNHAY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, valuation, profitability and institutional ownership. Valuation and Earnings This table compares Zoetis and Vifor […]
Vifor Pharma AG (OTCMKTS:GNHAY – Get Rating) was the target of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 200 shares, an increase of 100.0% from the May 15th total of 100 shares. Based on an average daily volume of 100 shares, the […]
Vifor Pharma AG (OTCMKTS:GNHAF – Get Rating) was the target of a large drop in short interest in May. As of May 31st, there was short interest totalling 2,900 shares, a drop of 75.2% from the May 15th total of 11,700 shares. Based on an average daily volume of 0 shares, the short-interest ratio is […]
Vifor Pharma (OTCMKTS:GNHAF – Get Rating) had its price objective lifted by analysts at UBS Group from CHF 167 to CHF 179 in a research note issued on Tuesday, The Fly reports. Shares of GNHAF opened at $173.25 on Tuesday. The business’s fifty day simple moving average is $174.60 and its two-hundred day simple moving […]